Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PH-797804 in RA Patients on Methotrexate
NCT00620685Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Oct 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PH-797804 in rheumatoid arthritis (RA), sponsored by Pfizer. Started Mar 2008; status: completed.
02
Drugs
PH-797804
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00620685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620685.